Clinical Trial

Dronabinol After Arthroscopic Surgery

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-04-13; most recent amendment 2026-05-22.
Status change: Recruiting → Active, Not Recruiting 2026-05-22
Status change: Not Yet Recruiting → Recruiting 2022-07-01
Trial Details
NCT Number NCT05335252
Lead Sponsor Northwestern University
Conditions Knee Osteoarthritis, Knee Injuries, Meniscus Tear, Synovitis of Knee, Knee Ligament Injury, Chondral Injury of Left Knee, Chondral Injury of Right Knee, Loose Body Knee
Enrollment 30 participants
Start Date 2022-06-28
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-27